Cutaneous Immune-Related Adverse Events (irAEs) to Immune Checkpoint Inhibitors: A Dermatology Perspective on Management [Formula: see text].

Muntyanu, Anastasiya; Netchiporouk, Elena; Gerstein, William; Gniadecki, Robert; Litvinov, Ivan V

Muntyanu, Anastasiya; Netchiporouk, Elena; Gerstein, William; Gniadecki, Robert; Litvinov, Ivan V.

Affiliation

Muntyanu A; 54473507266 Division of Dermatology, McGill University, Montreal, QC, Canada.
Netchiporouk E; 54473507266 Division of Dermatology, McGill University, Montreal, QC, Canada.
Gerstein W; 54473507266 Division of Dermatology, McGill University, Montreal, QC, Canada.
Gniadecki R; 3158 Division of Dermatology, University of Alberta, Edmonton, AB, Canada.
Litvinov IV; 54473507266 Division of Dermatology, McGill University, Montreal, QC, Canada.

J Cutan Med Surg ; 25(1): 59-76, 2021.

Article in En | MEDLINE | ID: mdl-32746624

Subject(s)

Drug Eruptions/therapy; Immune Checkpoint Inhibitors/adverse effects; Lichenoid Eruptions/therapy; Neoplasms/drug therapy; Pemphigoid, Bullous/drug therapy; Psoriasis/therapy; Alopecia Areata/chemically induced; Alopecia Areata/drug therapy; Body Surface Area; Drug Eruptions/etiology; Humans; Lichenoid Eruptions/chemically induced; Pemphigoid, Bullous/chemically induced; Psoriasis/chemically induced; Severity of Illness Index; Stevens-Johnson Syndrome/etiology; Stevens-Johnson Syndrome/therapy; Vasculitis/chemically induced; Vasculitis/drug therapy; Vitiligo/chemically induced; Vitiligo/therapy

Key words

CTLA-4; Grover's disease; PD-1; PD-L1; Stevens-Johnson syndrome (SJS); alopecia areata; atezolizumab; avelumab; bullous pemphigoid (BP); cemiplimab; durvalumab; immune checkpoint inhibitors; immune-related adverse events (irAE); ipilimumab; lichenoid reactions; maculopapular rash; nivolumab; pembrolizumab; psoriasis; sarcoidosis; skin rash; toxic epidermal necrolysis (TEN); vasculitis; vitiligo

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Psoriasis / Pemphigoid, Bullous / Lichenoid Eruptions / Drug Eruptions / Immune Checkpoint Inhibitors / Neoplasms Type of study: Etiology_studies / Guideline Limits: Humans Language: En Journal: J Cutan Med Surg Journal subject: DERMATOLOGIA Year: 2021 Type: Article Affiliation country: Canada

Fulltext

XML

PubMed Links

Search on Google